Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.64 |
| ▸ | HTR2B | P41595 | 1/20 | 0.64 |
| ▸ | PNMT | P11086 | 1/20 | 0.54 |
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | F7 | P08709 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | F3 | P13726 | 1/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30218134 | 1.00 | HTR2A (0.64) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL29724224 | 0.95 | HTR2A (0.64) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL5496769 | 0.95 | HTR2A (0.64) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| Hydrochloric Acid SCHEMBL27261560 | 0.92 | HTR2A (0.61) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL15962624 | 0.89 | — | — | |
| SCHEMBL23188936 | 0.89 | HTR2A (0.53) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| Ammonia Solution, Strong SCHEMBL10465265 | 0.86 | HTR2A (0.67) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL5143608 | 0.81 | HTR2A (0.46) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL12430509 | 0.81 | HTR2A (0.46) | HTR2AHTR2CHTR2BPNMTKDM1A | |
| SCHEMBL16559360 | 0.79 | HTR2A (0.58) | HTR2AHTR2CHTR2BPNMTKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118895515-A | Application of platinum carbon catalyst-loaded electrode in aryl compound benzyl carbon-hydrogen bond oxidation reaction | 南京航空航天大学 | 2024-11-05 | — | — | CN | claimed |
| CN-119118881-B | Guanidine-containing 5-chloroindane compound, and preparation method and application thereof | 中国农业大学 | 2026-01-02 | — | — | CN | disclosed |
| CN-119118881-B | Guanidine-containing 5-chloroindane compound, and preparation method and application thereof | 中国农业大学 | 2026-01-02 | — | — | CN | disclosed |
| CN-119118881-A | Guanidine-containing 5-chloroindane compound, and preparation method and application thereof | 中国农业大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-119118881-A | Guanidine-containing 5-chloroindane compound, and preparation method and application thereof | 中国农业大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-119118881-A | Guanidine-containing 5-chloroindane compound, and preparation method and application thereof | 中国农业大学 | 2024-12-13 | — | — | CN | disclosed |
| CN-118895515-A | Application of platinum carbon catalyst-loaded electrode in aryl compound benzyl carbon-hydrogen bond oxidation reaction | 南京航空航天大学 | 2024-11-05 | — | — | CN | disclosed |
| CN-118591521-A | Process for preparing 5-chloro-2, 3-dihydro-1H-inden-1-one | 安道麦马克西姆有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118591521-A | Process for preparing 5-chloro-2, 3-dihydro-1H-inden-1-one | 安道麦马克西姆有限公司 | 2024-09-03 | — | — | CN | disclosed |
| EP-4392410-A1 | TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS FOR USE AS THERAPEUTICS | The University of British Columbia (CA) | 2024-07-03 | — | — | EP | disclosed |
| EP-1660427-A4 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORP (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-20060178366-A1 | Compounds for the treatment of inflammatory disorders | SCHERING CORPORATION | 2006-08-10 | — | — | US | disclosed |
| EP-1660427-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005123724-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| EP-1603887-A1 | HIV REPLICATION INHIBITING PYRIMIDINES AND TRIAZINES | Tibotec Pharmaceuticals Ltd. (IE) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005016862-A1 | SUBSTITUTED ARYLALKANOIC ACID DERIVATIVE AND USE THEREOF | ASAHI KASEI PHARMA CORPORATION (JP) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004074261-A1 | HIV REPLICATION INHIBITING PYRIMIDINES AND TRIAZINES | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2004-09-02 | — | — | WO | disclosed |
| EP-0063418-B1 | INDANYLOXY- AND TETRALINYLOXY-PHENOXYPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARING THEM, AND HERBICIDAL PROCESSES AND COMPOSITIONS UTILISING THEM | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-10-03 | — | — | EP | disclosed |
| US-4431834-A | INDAN OR TETRALIN DERIVATIVES; PLANT GROWTH REGULATORS; GRASSES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-02-14 | — | — | US | disclosed |
| EP-0063418-A1 | Indanyloxy- and tetralinyloxy-phenoxypropionic acid derivatives, processes for preparing them, and herbicidal processes and compositions utilising them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178366-A1 | Compounds for the treatment of inflammatory disorders | MMP12, ADAMTS1, TNF | HTR2A 4340/4885HTR2C 4579/4885HTR2B 3615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.